Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose reduction of biologics in patients with plaque psoriasis: a review.
van Riel CAM, Michielsens CAJ, van Muijen ME, van der Schoot LS, van den Reek JMPA, de Jong EMGJ. van Riel CAM, et al. Among authors: michielsens caj. Front Pharmacol. 2024 Mar 28;15:1369805. doi: 10.3389/fphar.2024.1369805. eCollection 2024. Front Pharmacol. 2024. PMID: 38606178 Free PMC article. Review.
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long-term Child-CAPTURE registry.
Bronckers IMGJ, de Jong EMGJ, Michielsens CAJ, Groenewoud HMM, van de Kerkhof PCM, Seyger MMB. Bronckers IMGJ, et al. Among authors: michielsens caj. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e894-e897. doi: 10.1111/jdv.18984. Epub 2023 Mar 9. J Eur Acad Dermatol Venereol. 2023. PMID: 36800316 No abstract available.
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial.
Michielsens CA, den Broeder N, van den Hoogen FH, Mahler EA, Teerenstra S, van der Heijde D, Verhoef LM, den Broeder AA. Michielsens CA, et al. Ann Rheum Dis. 2022 Oct;81(10):1392-1399. doi: 10.1136/annrheumdis-2022-222260. Epub 2022 Jun 14. Ann Rheum Dis. 2022. PMID: 35701155 Clinical Trial.
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial.
Michielsens CAJ, Boers N, den Broeder N, Wenink MH, van der Maas A, Mahler EAM, Mulder MLM, van der Heijde D, van den Hoogen FHJ, Verhoef LM, den Broeder AA. Michielsens CAJ, et al. Trials. 2020 Jan 15;21(1):90. doi: 10.1186/s13063-019-4000-5. Trials. 2020. PMID: 31941544 Free PMC article. Clinical Trial.
Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
Michielsens C, Bolhuis TE, van Gaalen FA, van den Hoogen F, Verhoef LM, den Broeder N, den Broeder AA. Michielsens C, et al. Scand J Rheumatol. 2024 May;53(3):180-187. doi: 10.1080/03009742.2023.2213509. Epub 2023 Jun 20. Scand J Rheumatol. 2024. PMID: 37339375 Free article.